Exodus Point Capital Management, LP Ironwood Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$8.25 - $11.35 $1.04 Million - $1.43 Million	125,721 Added 271.95%	171,950 $1.66 Million
Q2 2023 Aug 10, 2023	SELL	$10.1 - $11.6 $4.3 Million - $4.94 Million	-425,794 Reduced 90.21%	46,229 $492,000
Q1 2023 May 11, 2023	BUY	$10.37 - $12.56 $2.28 Million - $2.76 Million	219,806 Added 87.15%	472,023 $4.97 Million
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $2.5 Million - $3.14 Million	252,217 New	252,217 $3.13 Million
Q3 2022 Nov 10, 2022	SELL	$10.14 - $12.38 $581,569 - $710,042	-57,354 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$11.05 - $12.72 $7.47 Million - $8.6 Million	-676,413 Reduced 92.18%	57,354 $661,000
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $4.42 Million - $5.37 Million	-416,978 Reduced 36.24%	733,767 $9.23 Million
Q4 2021 Feb 11, 2022	BUY	$10.86 - $13.95 $6.19 Million - $7.95 Million	569,760 Added 98.07%	1,150,745 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $2.25 Million - $2.63 Million	188,644 Added 48.08%	580,985 $7.59 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $2.11 Million - $2.72 Million	207,245 Added 111.97%	392,341 $5.05 Million
Q1 2021 May 17, 2021	SELL	$9.04 - $11.86 $1.64 Million - $2.16 Million	-181,876 Reduced 49.56%	185,096 $2.07 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $511,225 - $689,165	56,489 Added 18.19%	366,972 $4.18 Million
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $2.79 Million - $3.33 Million	310,483 New	310,483 $2.79 Million
Q1 2020 May 15, 2020	SELL	$8.58 - $14.01 $156,653 - $255,794	-18,258 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.22 - $14.0 $54,572 - $92,946	-6,639 Reduced 26.67%	18,258 $243,000
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $213,865 - $272,871	24,897 New	24,897 $214,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$80.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$77.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$57.9 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$39.8 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$35 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account